This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Flowers Foods (FLO) Gains on Acquisitions, Cost Woes Persist
by Zacks Equity Research
Flowers Foods (FLO) is gaining from buyouts and efficient pricing strategy. However, rising production costs are a drag on performance.
Coty Up More Than 35% in 3 Months, Luxury Unit a Key Driver
by Zacks Equity Research
Coty (COTY) gains from strength in its Luxury business. However, challenges in the Consumer Beauty unit persist.
Avon Secures Shareholder Approval for Takeover by Natura
by Zacks Equity Research
Avon's (AVP) efforts to drive productivity, improve brand relevance and digital capabilities bode well.
Is e.l.f. Beauty (ELF) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (ELF) Outperforming Other Consumer Staples Stocks This Year?
Avon Stock Gains 42% on Open Up Initiative & Other Efforts
by Zacks Equity Research
Avon's (AVP) Open Up strategy and productivity efforts appear promising. Also, its endeavors to expand the e-commerce business are driving growth.
International Flavors-Neptune Team to Co-Develop CBD Products
by Zacks Equity Research
International Flavors (IFF) focused on developing hemp-derived CBD products for customers in natural health & wellness products.
Coty's (COTY) Stock Up More Than 10% on Q1 Earnings Beat
by Zacks Equity Research
Coty (COTY) gains from a strong Luxury unit in first-quarter fiscal 2020. However, the Consumer Beauty unit is weak.
E.l.f. Beauty (ELF) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 66.67% and 12.18%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin's (NUS) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Nu Skin's (NUS) third-quarter earnings are affected by limited sales meetings in Mainland China.
5 Must-See Earnings Charts This Week
by Tracey Ryniec
Wellness and lifestyle companies have been front and center thanks to Millennial demands for experiences. These 5 companies are some of the top names.
Things to Know Before Monster Beverage's (MNST) Q3 Earnings
by Zacks Equity Research
Monster Beverage's (MNST) third-quarter 2019 results are expected to reflect momentum in the energy drinks business as well as the benefit of product innovation and regular product launches.
Factors Likely to Impact E.l.f. Beauty (ELF) in Q2 Earnings
by Zacks Equity Research
Elevated tariff costs might have weighed on E.l.f Beauty's (ELF) Q2 performance. However, cost-saving efforts and loyalty programs are likely to have provided some cushion.
International Flavors' (IFF) Q3 Earnings & Sales Lag Estimates
by Zacks Equity Research
International Flavors (IFF) records growth in operating margin and generates strong free cash flow, aided by productivity savings and acquisition-related synergies in Q3.
FEMSA Comercio Seals JV with Raizen, Expands Brazil Footprint
by Zacks Equity Research
FEMSA Comercio, a unit of FEMSA (FMX), closes the previously entered JV agreement with Raizen Conveniencias in Brazil, after receiving the necessary regulatory approvals.
Things to Know Before Keurig Dr Pepper's (KDP) Q3 Earnings
by Zacks Equity Research
Changes in the Allied Brands portfolio and currency woes are likely to get reflected in Keurig Dr Pepper's (KDP) third-quarter sales. Higher operating income and lower debt might have aided earnings.
Factors Setting the Tone for Inter Parfums (IPAR) Q3 Earnings
by Zacks Equity Research
Inter Parfums (IPAR) Q3 earnings is likely to have gained from strength in U.S. and European-based operations.
Here's How Nu Skin (NUS) Looks Just Ahead of Q3 Earnings
by Zacks Equity Research
Nu Skin's (NUS) third-quarter 2019 results are expected to reflect impacts of foreign currency headwinds.
Avon (AVP) Q3 Earnings Beat Estimates, Sales Decline Y/Y
by Zacks Equity Research
Avon's (AVP) focus on pricing and productivity initiatives drives adjusted operating margin. Also, the company is progressing well with its "Open Up Avon" strategy.
Church & Dwight (CHD) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Church & Dwight's (CHD) Q3 earnings and sales improve on gains from most product categories.
Estee Lauder (EL) Stock Down Despite Q1 Earnings & Sales Beat
by Zacks Equity Research
The Estee Lauder's (EL) first-quarter fiscal 2020 results reflect strength in the Skin Care category, Estee Lauder brand, and travel retail and online channels.
Factors to Know Ahead of Church & Dwight's (CHD) Q3 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) Q3 performance is likely to have benefited from international business, acquisitions and market share gains.
E.l.f. Beauty (ELF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
E.l.f. Beauty (ELF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Decide Newell's (NWL) Fate in Q3 Earnings
by Zacks Equity Research
Newell's (NWL) third-quarter results are expected to reflect gains from innovation, e-commerce and cost savings. However, lower core sales and adverse currency might have been drags.
What's in Store for International Flavors' (IFF) Q3 Earnings?
by Zacks Equity Research
International Flavors' (IFF) Q3 performance likely to reflect benefits from cost and productivity initiatives, margin improvements and acquisition-related synergies amid raw-material cost inflation.
Things to Know Ahead of Corteva's (CTVA) Q3 Earnings Release
by Zacks Equity Research
Corteva's (CTVA) Q3 performance is likely to have been impacted by softness in North American market. However, the company is on track with cost saving initiatives.